Diagnosis and treatment of latent tuberculosis infection;Diagnosi e trattamento dell'ii tubercolare latente

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 32, Issue 3, 2010, Pages 264-268

  Sotgiu, Giovanni ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Chemoprophylaxis; Immunodiagnostic test; Latent infection; Tuberculosis

Indexed keywords

ARTICLE; HUMAN; LATENT TUBERCULOSIS; TUBERCULIN TEST;

HUMANS; LATENT TUBERCULOSIS; TUBERCULIN TEST;

EID: 77958067970     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva, Switzerland, 2009. WHO/HTM/TB/2009.426.
2. Clancy L, Rieder H L, Enarson DA, Spinaci S. Tuberculosis elimination in the countries of Europe and other industrialized countries. Based on a workshop held at Wolfheze, Netherlands, 4-9 March 1990, under the joint auspices of the IUATLD (Europe region) and WHO. Eur Respir J 1991; 4: 1288-1295
3. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973
4. The National Collaborating Centre for Chronic Conditions. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, ed. London: Royal College of Physicians, 2006.
5. Cook V J, Hemaiidez-Garduno E, Elwood RK. Risk of tuberculosis in screened subjects without known risk factors for active disease. Int J Tuberc Lung Dis 2008; 12: 903-908
6. Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, Villiger PM, Zellweger JP. Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly 2007; 137: 620-622
7. Landry J, Menzies D. Tuberculosis. State of the Art series. Number 2 in the series. Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis 2008; 12: 1352-1364
8. Smieja M, Marchetti C, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews 1999,Issue l.Art. No.:CD001363. DOI: 10.1002/14651858.CD001363
9. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014-1018
10. Quigley MA, Mwinga A, Hosp M Lisse I, Fuchs D, Porter JDH, Godfrey-FaussettP. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS 2001; 15: 215-222